tivozanib

Aveo CEO Michael Bailey

Biotech

After surprise FDA win, Aveo reverts to normal as partner splits

After getting an FDA approval for its long-suffering cancer med from the FDA this month, Aveo’s brief positive news was upset by reverting to type.

Ben Adams Mar 15, 2021 8:55am

Renal cell carcinoma histology

Aveo's phoenix drug tivozanib rises up in Europe

Aug 28, 2017 9:38am

EMA

Aveo soars as long-beleaguered cancer drug nears approval

Jun 23, 2017 8:43am

Aveo takes baby step forward for once-rejected tivozanib

Feb 23, 2017 10:23am